Skip to content
healthcare.dev

CARBIDOPA, LEVODOPA AND ENTACAPONE

NDC 16571-691, CARBIDOPA, LEVODOPA AND ENTACAPONE, tablet, film coated, from Rising Pharma Holdings, Inc..

Product NDC
16571-691
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213212
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-691 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBIDOPA25 mg/1
  • LEVODOPA100 mg/1
  • ENTACAPONE200 mg/1

Pharmacologic classes

Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]; Catechol O-Methyltransferase Inhibitors [MoA]; Catechol-O-Methyltransferase Inhibitor [EPC]

Package NDCNDC-11Package
16571-691-0116571069101100 TABLET, FILM COATED in 1 BOTTLE (16571-691-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2f8e82d7-6baf-456a-b8c3-4fda6e317902
  • NADAC price for package 16571069101

    GET /v1/drugs/nadac/16571069101

Use it

Look up 16571-691 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-691 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-691. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.